Literature DB >> 8790152

Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia.

T Motoji1, M Takanashi, S Motomura, W H Wang, H Shiozaki, M Aoyama, H Mizoguchi.   

Abstract

Thrombopoietin stimulated blast colony formation in 11/20 acute myelogenous leukaemia (AML) patients studied. The FAB subtypes of the blasts responding to thrombopoietin were not restricted to those of the megakaryocyte lineage, but also included M1-M5 AML blasts. The morphology of colony cells produced by megakaryocytic blasts showed megakaryocytoid features, whereas colony cells produced by M1-M5 AML blasts remained myeloblasts. An increase in CD41 was observed in the cells of colonies produced by blasts from the megakaryocyte lineage involving leukaemia and chronic myeloid leukaemia in blastic crisis. Thrombopoietin receptor was observed on leukaemic blasts which formed colonies following incubation with thrombopoietin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790152     DOI: 10.1046/j.1365-2141.1996.d01-1832.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles.

Authors:  J G Thomas; J M Olson; S J Tapscott; L P Zhao
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

2.  Thrombopoietin receptor levels in tumor cell lines and primary tumors.

Authors:  Connie L Erickson-Miller; Antony Chadderton; Anna Gibbard; Jennifer Kirchner; Kodandaram Pillarisetti; Katherine Baker; Lini Pandite; Iman El-Hariry; Yasser Mostafa Kamel; Yuan Liu; Anne-Marie Martin; Conrad Messam
Journal:  J Oncol       Date:  2010-12-28       Impact factor: 4.375

3.  Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.

Authors:  Connie L Erickson-Miller; Kodandaram Pillarisetti; Jennifer Kirchner; David J Figueroa; Lone Ottesen; Anne-Marie Martin; Yuan Liu; Yasser Mostafa Kamel; Conrad Messam
Journal:  BMC Cancer       Date:  2012-09-11       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.